Table 2.

Univariate analysis of clinicopathologic parameters and IKKα expression for patient survival

FactorsP*
Age (≤50 vs. >50 y)0.1855
T stage (T1/2 vs. T3/4)0.0003
Lymph node status (N− vs. N+)0.0814
Clinical stage (stage 1/2 vs. 3/4)0.0034
Histologic differentiation (well vs. moderately/poorly differentiated)0.0024
IKKα expression (≤10% vs. >10%)0.0011
  • * Log-rank test.

  • N+, cases with lymph node metastasis.